{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03479762","recordId":"NCT03479762","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03479762-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03479762.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03479762.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-03-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-21","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"f0467fe97737110fa845d8f2716fdd8da556289f85a96270095ef1e8eda86f72","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-05-16","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"54e343dead28ce026d82ce9d3acceb6bdf96f7cbcce63f42a1abc5bf8a363c7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Conditions","Eligibility","IPDSharing","Outcome Measures","Oversight","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-27","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"c43c42aee73ab0390e14565097e77da280460869272bdf691d6d6149ef11f336","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-05","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"faad25a89d06ca3a29d1217ba2002d17ffc4fccea9276419d6d1f31bcf36cff7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2020-04-20","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"439d8d2ea6452c9bc37d2b5d034c767fd79e28e8722eedfecbdd03b0d74660ba","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2021-04-27","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"484e2fde97173c28a5ed426974b08f38b317d1c88c585fee2da393f8265637d2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-08","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"e03c2a198bdab1c7a98595f4aa580853e688c4739c1a6c53c67e135333e1f9cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-23","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"e20628a8ba0457f6220629ea04bbf61ae1619a8d479128311209bd3b890e563c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=8&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5d5ff4a80c7519af853c9723fe1586d82546462842105914f88331aeeac73f43"}}